Characteristics of patients and subjects used in this study
| Biopsies | Stools | ||||
|---|---|---|---|---|---|
| UC patients (n = 10) | Controls (n = 10) | Infants (n = 10) | Adults (n = 10) | Elderly (n = 10) | |
| *Values are mean (SEM). | |||||
| UC, ulcerative colitis. | |||||
| Age (y) | |||||
| Range | 28–65 | 19–76 | 22 days–23 mo | 20–35 | 64–83 |
| Mean (SEM) | 50.2 (2.8) | 50.8 (4.7) | 1.01 (0.18) | 26.7 (1.2) | 71.7 (1.2) |
| Sex (M/F) | 4/6 | 4/6 | 5/5 | 3/7 | 0/10 |
| UC duration (y)* | 9.2 (1.6) | – | – | – | – |
| Therapy for UC | – | – | – | ||
| None | 2 | – | – | – | – |
| Balsalazide | 2 | – | – | – | – |
| Salazopyrine | 2 | – | – | – | – |
| Minocycline | 1 | – | – | – | – |
| Asacol | 3 | – | – | – | – |